142 related articles for article (PubMed ID: 36037830)
1. Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial.
Zhu W; Cao Y; Ye M; Huang H; Wu Y; Ma J; Dong Y; Liu X; Liu C; Lip GYH
Thromb Haemost; 2023 Jan; 123(1):85-96. PubMed ID: 36037830
[TBL] [Abstract][Full Text] [Related]
2. CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Zhu W; Wu Y; Zhou Y; Liang W; Xue R; Wu Z; Dong Y; Liu C
Cardiovasc Drugs Ther; 2020 Dec; 34(6):763-772. PubMed ID: 32583288
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients.
Wu Y; Xie Z; Liang W; Xue R; Wu Z; Wu D; He J; Zhu W; Liu C
ESC Heart Fail; 2021 Apr; 8(2):1369-1377. PubMed ID: 33506643
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of B-Type Natriuretic Peptide for Predicting the Risk of Stroke in Patients With Heart Failure With Preserved Ejection Fraction.
Liu X; Abudukeremu A; Yu P; Cao Z; Sun R; Wu M; Chen Z; Ma J; Zhu W; Chen Y; Zhang Y; Wang J
J Am Heart Assoc; 2022 Aug; 11(15):e024302. PubMed ID: 35904188
[TBL] [Abstract][Full Text] [Related]
5. Impact of diabetic retinopathy on prognosis of patients with heart failure with preserved ejection fraction.
Yang Y; Zhou Y; Cao Y; Dong Y; Liu C; Zhu W
Nutr Metab Cardiovasc Dis; 2022 Jul; 32(7):1711-1718. PubMed ID: 35606228
[TBL] [Abstract][Full Text] [Related]
6. Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials.
Cunningham JW; Vaduganathan M; Claggett BL; John JE; Desai AS; Lewis EF; Zile MR; Carson P; Jhund PS; Kober L; Pitt B; Shah SJ; Swedberg K; Anand IS; Yusuf S; McMurray JJV; Pfeffer MA; Solomon SD
JACC Heart Fail; 2020 Aug; 8(8):618-626. PubMed ID: 32387067
[TBL] [Abstract][Full Text] [Related]
7. Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction.
Cao Y; Guo S; Dong Y; Liu C; Zhu W
ESC Heart Fail; 2023 Jun; 10(3):1771-1780. PubMed ID: 36864701
[TBL] [Abstract][Full Text] [Related]
8. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.
Sandesara PB; Hammadah M; Samman-Tahhan A; Kelli HM; O'Neal WT
Clin Cardiol; 2017 Sep; 40(9):692-696. PubMed ID: 28444995
[TBL] [Abstract][Full Text] [Related]
9. Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist).
Hegde SM; Claggett B; Shah AM; Lewis EF; Anand I; Shah SJ; Sweitzer NK; Fang JC; Pitt B; Pfeffer MA; Solomon SD
Circulation; 2017 Sep; 136(11):982-992. PubMed ID: 28637881
[TBL] [Abstract][Full Text] [Related]
10. Ischemic risk in patients with heart failure with preserved ejection fraction: A post hoc analysis of the TOPCAT data.
He X; Dong B; Liang W; Wu Y; Chen Y; Dong Y; He J; Liu C
Atherosclerosis; 2022 Mar; 344():1-6. PubMed ID: 35101783
[TBL] [Abstract][Full Text] [Related]
11. C
Liang W; Wu Y; Xue R; Wu Z; Wu D; He J; Dong Y; Lip GYH; Zhu W; Liu C
BMC Med; 2021 Feb; 19(1):44. PubMed ID: 33596909
[TBL] [Abstract][Full Text] [Related]
12. Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial.
Lewis EF; Claggett B; Shah AM; Liu J; Shah SJ; Anand I; O'Meara E; Sweitzer NK; Rouleau JL; Fang JC; Desai AS; Retta TM; Solomon SD; Heitner JF; Stamos TD; Boineau R; Pitt B; Pfeffer MA
Circ Heart Fail; 2018 Mar; 11(3):e004457. PubMed ID: 29664406
[TBL] [Abstract][Full Text] [Related]
13. Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial.
Myhre PL; Vaduganathan M; Claggett BL; Anand IS; Sweitzer NK; Fang JC; O'Meara E; Shah SJ; Desai AS; Lewis EF; Rouleau J; Pitt B; Pfeffer MA; Solomon SD
JAMA Cardiol; 2018 Oct; 3(10):1000-1005. PubMed ID: 30140899
[TBL] [Abstract][Full Text] [Related]
14. Machine Learning Prediction of Mortality and Hospitalization in Heart Failure With Preserved Ejection Fraction.
Angraal S; Mortazavi BJ; Gupta A; Khera R; Ahmad T; Desai NR; Jacoby DL; Masoudi FA; Spertus JA; Krumholz HM
JACC Heart Fail; 2020 Jan; 8(1):12-21. PubMed ID: 31606361
[TBL] [Abstract][Full Text] [Related]
15. Heart rate and the risk of adverse outcomes in patients with heart failure with preserved ejection fraction.
O'Neal WT; Sandesara PB; Samman-Tahhan A; Kelli HM; Hammadah M; Soliman EZ
Eur J Prev Cardiol; 2017 Jul; 24(11):1212-1219. PubMed ID: 28482692
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction.
Shin SH; Claggett B; Inciardi RM; Santos ABS; Shah SJ; Zile MR; Pfeffer MA; Shah AM; Solomon SD
J Am Heart Assoc; 2021 Aug; 10(15):e019545. PubMed ID: 34325519
[TBL] [Abstract][Full Text] [Related]
17. Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction.
Shen L; Jhund PS; Anand IS; Carson PE; Desai AS; Granger CB; Køber L; Komajda M; McKelvie RS; Pfeffer MA; Solomon SD; Swedberg K; Zile MR; McMurray JJV
Clin Res Cardiol; 2021 Aug; 110(8):1234-1248. PubMed ID: 33301080
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
[TBL] [Abstract][Full Text] [Related]
19. Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction.
Segar MW; Patel RB; Patel KV; Fudim M; DeVore AD; Martens P; Hedayati SS; Grodin JL; Tang WHW; Pandey A
JAMA Cardiol; 2021 Jan; 6(1):68-77. PubMed ID: 33206129
[TBL] [Abstract][Full Text] [Related]
20. Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial.
Anand IS; Claggett B; Liu J; Shah AM; Rector TS; Shah SJ; Desai AS; O'Meara E; Fleg JL; Pfeffer MA; Pitt B; Solomon SD
JACC Heart Fail; 2017 Apr; 5(4):241-252. PubMed ID: 28359411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
